Tower Research Capital (TRC)’s Bio-Path Holdings Inc BPTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,350
| Closed | -$2.73K | – | 6057 |
|
|
2024
Q4 | $2.73K | Sell |
2,350
-1,021
| -30% | -$952 | ﹤0.01% | 4786 |
|
|
2024
Q3 | $3.07K | Sell |
3,371
-362
| -10% | -$498 | ﹤0.01% | 4899 |
|
|
2024
Q2 | $7.47K | Buy |
3,733
+1,799
| +93% | +$4.93K | ﹤0.01% | 4462 |
|
|
2024
Q1 | $7.97K | Buy |
1,934
+1,448
| +298% | +$10.9K | ﹤0.01% | 4104 |
|
|
2023
Q4 | $4.5K | Sell |
486
-452
| -48% | -$4.75K | ﹤0.01% | 4948 |
|
|
2023
Q3 | $6.94K | Buy |
938
+643
| +218% | +$8.94K | ﹤0.01% | 4536 |
|
|
2023
Q2 | $10.5K | Sell |
295
-29
| -9% | -$895 | ﹤0.01% | 4108 |
|
|
2023
Q1 | $9K | Sell |
324
-57
| -15% | -$2.05K | ﹤0.01% | 4581 |
|
|
2022
Q4 | $12K | Buy |
381
+212
| +125% | +$9.29K | ﹤0.01% | 3774 |
|
|
2022
Q3 | $11K | Buy |
169
+112
| +196% | +$8.51K | ﹤0.01% | 4487 |
|
|
2022
Q2 | $4K | Sell |
57
-4
| -7% | -$270 | ﹤0.01% | 5291 |
|
|
2022
Q1 | $5K | Buy |
+61
| New | +$4.45K | ﹤0.01% | 5136 |
|
|
2021
Q4 | – | Sell |
-70
| Closed | -$7K | – | 6731 |
|
|
2021
Q3 | $7K | Buy |
70
+60
| +600% | +$7.2K | ﹤0.01% | 4700 |
|
|
2021
Q2 | $1K | Buy |
+10
| New | +$1.23K | ﹤0.01% | 5290 |
|
|
2021
Q1 | – | Sell |
-84
| Closed | -$6K | – | 5836 |
|
|
2020
Q4 | $6K | Buy |
+84
| New | +$6.3K | ﹤0.01% | 4576 |
|
|
2020
Q3 | – | Sell |
-135
| Closed | -$14K | – | 5183 |
|
|
2020
Q2 | $14K | Buy |
+135
| New | +$14K | ﹤0.01% | 3879 |
|
|
2017
Q3 | – | Sell |
-3
| Closed | -$4K | – | 4233 |
|
|
2017
Q2 | $4K | Sell |
3
-29
| -91% | -$60.8K | ﹤0.01% | 2139 |
|
|
2017
Q1 | $105K | Buy |
+32
| New | +$116K | 0.01% | 459 |
|
|
2016
Q2 | – | Hold |
0
| – | -$2K | – | 5115 |
|
|
2016
Q1 | – | Sell |
-1
| Closed | -$6.48K | – | 3473 |
|
|
2015
Q4 | $6K | Buy |
+1
| New | +$5.83K | ﹤0.01% | 2846 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 4964 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 5175 |
|
|
2014
Q4 | – | Sell |
-18
| Closed | -$141K | – | 4836 |
|
|
2014
Q3 | $141K | Buy |
18
+15
| +500% | +$145K | 0.02% | 687 |
|
|
2014
Q2 | $38K | Buy |
+3
| New | +$32.9K | ﹤0.01% | 1444 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 3698 |
|
Other funds holding BPTH
Tower Research Capital (TRC)'s BPTH Position: Q1 2025 in Review
Tower Research Capital (TRC) sold out of Bio-Path Holdings Inc (BPTH) in Q1 2025, closing a stake of 2,350 shares — an estimated $2.73K sold.
Tower Research Capital (TRC) first reported a position in BPTH in Q2 2014 and held it in 21 quarters. The position peaked at $141K in Q3 2014. 2 funds tracked by Wall St. Rank hold BPTH as of Q1 2025.
- Tower Research Capital (TRC) reported no remaining Bio-Path Holdings Inc position as of Q1 2025 after selling out during the quarter.
- Tower Research Capital (TRC) sold 2,350 Bio-Path Holdings Inc shares in Q1 2025, an estimated $2.73K.
- Tower Research Capital (TRC) first reported a position in Bio-Path Holdings Inc in Q2 2014 and held it in 21 quarters.
- Tower Research Capital (TRC)'s Bio-Path Holdings Inc position peaked at $141K in Q3 2014.
- 2 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q1 2025.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.